Name | POTREBITEL'SKIY GARAZHNO-STROITEL'NYY KOOPERATIV N807 G.SAMARA |
|---|
INN | 6319039148 |
|---|
KPP | 631901001 |
|---|
OGRN | 1026301711644 |
|---|
OKPO | 40948938 |
|---|
Address | 443087, Samarskaya Oblast', g. Samara, sh. Moskovskoe, d. D.177A |
|---|
Phone | 56-17-49 |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 52.21.24 | Core activity | Activities of Parking for vehicles | | 41.20 | Additional activity | Construction of buildings |
Registration date | 27.11.2002 |
|---|
Registering department | INSPEKTSIYA MNS RF PO PROMYSHLENNOMU R-NU |
|---|
|
GSK N807 G.SAMARY (Samara Oblast; INN 6319039148) was registered on 27 Nov 2002. Type of ownership of GSK N807 G.SAMARY - Comsumer cooperatives. Form of ownership of GSK N807 G.SAMARY - Private property. Principal activities of GSK N807 G.SAMARY: activities of parking for vehicles (52.21.24), construction of buildings (41.20). |
Economic indicators2023
Net profit (RAS) of GSK N807 G.SAMARY dropped in 2023 by 0.86% to 1.15 million RUB from 1.16 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 0.92% to 1.18 million RUB from 1.19 million RUB in 2022; sales profit fell by 0.92% to 1.18 million RUB from 1.19 million RUB. 2022
Net profit (RAS) of GSK N807 G.SAMARY grew over 2022 by 13.65% to 1.16 million RUB from 1.02 million RUB over 2021, the company informed. Revenue increased in the accounting period by 13.73% to 1.19 million RUB from 1.05 million RUB over 2021; sales profit went up by 13.73% to 1.19 million RUB from 1.05 million RUB. 2021
Net profit (RAS) of GSK N807 G.SAMARY grew over 2021 by 11.99% to 1.02 million RUB from 909.00 thousand RUB over 2020, the company informed. Revenue increased in the accounting period by 11.95% to 1.05 million RUB from 937.00 thousand RUB over 2020; sales profit went up by 11.95% to 1.05 million RUB from 937.00 thousand RUB. 2020
Net profit (RAS) of GSK N807 G.SAMARY grew over 2020 by 3.18% to 909.00 thousand RUB from 881.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period by 3.19% to 937.00 thousand RUB from 908.00 thousand RUB over 2019; sales profit went up by 3.19% to 937.00 thousand RUB from 908.00 thousand RUB. 2019
Net profit (RAS) of GSK N807 G.SAMARY grew over 2019 by 8.77% to 881.00 thousand RUB from 810.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 8.74% to 908.00 thousand RUB from 835.00 thousand RUB over 2018; sales profit went up by 8.74% to 908.00 thousand RUB from 835.00 thousand RUB. 2018
Net profit (RAS) of GSK N807 G.SAMARY grew over 2018 by 6.30% to 810.00 thousand RUB from 762.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 6.37% to 835.00 thousand RUB from 785.00 thousand RUB over 2017; sales profit went up by 6.37% to 835.00 thousand RUB from 785.00 thousand RUB. 2017
Net profit (RAS) of GSK N807 G.SAMARY over 2017 was the same as in 2016 reaching 762.00 thousand RUB, the company informed. Revenue decreased in the accounting period by 17.46% to 785.00 thousand RUB from 951.00 thousand RUB in 2016; sales profit fell by 17.46% to 785.00 thousand RUB from 951.00 thousand RUB. 2016
Net profit (RAS) of GSK N807 G.SAMARY dropped in 2016 by 36.37% to 761.00 thousand RUB from 1.20 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 36.39% to 951.00 thousand RUB from 1.50 million RUB in 2015; sales profit fell by 36.39% to 951.00 thousand RUB from 1.50 million RUB. 2014
Net profit (RAS) of GSK N 807 G.SAMARY dropped in 2014 by 14.95% to 842.00 thousand RUB from 990.00 thousand RUB over the same period in 2013, the company informed. Revenue decreased in the accounting period by 14.94% to 1.05 million RUB from 1.24 million RUB in 2013; sales profit fell by 14.94% to 1.05 million RUB from 1.24 million RUB. 2013
Net profit (RAS) of GSK N 807 G.SAMARY dropped in 2013 by 6.87% to 990.00 thousand RUB from 1.06 million RUB over the same period in 2012, the company informed. Revenue decreased in the accounting period by 6.85% to 1.24 million RUB from 1.33 million RUB in 2012; sales profit fell by 6.85% to 1.24 million RUB from 1.33 million RUB. 2012
Net profit (RAS) of GSK N 807 G.SAMARY grew over 2012 by 6.19% to 1.06 million RUB from 1.00 million RUB over 2011, the company informed. Revenue increased in the accounting period by 6.24% to 1.33 million RUB from 1.25 million RUB over 2011; sales profit went up by 6.24% to 1.33 million RUB from 1.25 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|